CAN/653
WTO/TBT
Canada - 11 - Health care technology
- 30 - Pharmaceutical products
2021-10-31
2021-09-13
Prescription status of medicinal ingredients for human and veterinary use (ICS: 11.120.01; HS: 3004.90)
Notice of Consultation - Prescription Drug List (PDL): Brimonidine (1 page, available in English and French)
The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to revise the listing for brimonidine or its salts, by adding a qualifier to the human and veterinary parts of the Prescription Drug List.
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/consultation-brimonidine.html (English)
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/consultation-brimonidine.html (French)
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/consultation-brimonidine.html (French)